Tumores Gastrintestinais

Câncer anal: Diretrizes de Prática Clínica da ESMO para diagnóstico, tratamento e seguimento.

1 Jul, 2021 | 10:10h

Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up – Annals of Oncology

Comentário no Twitter

Now available in Annals of Oncology, the @myESMO clinical practice guidelines for the diagnosis, treatment and follow-up of anal cancer, a rare disease accounting for less than 1% of all cancers https://t.co/usnFsd00BJ pic.twitter.com/bI0v60j8Ft

— Annals of Oncology (@Annals_Oncology) June 30, 2021

Diretrizes de prática clínica baseada em evidências para tratamento de pólipos colorretais.

25 Jun, 2021 | 10:31h

Evidence-based clinical practice guidelines for management of colorectal polyps – Journal of Gastroenterology

Estudo randomizado: Quimioterapia de intensidade reduzida em pacientes idosos frágeis com câncer gastresofágico avançado propicia uma melhor experiência ao paciente, sem perda significativa no controle da doença.

20 Mai, 2021 | 10:42h

Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer: The GO2 Phase 3 Randomized Clinical Trial – JAMA Oncology

Comentário: Lowering Chemo Dose Achieved Happier Patients, Good Outcomes in Elderly GI Cancer Patients – Physician’s Weekly

Comentário no Twitter

The GO2 trial tested reduced intensity of chemo for pts w adv gastroesophageal cancer & found reducing intensity led to comparable survival but w improved patient experience, & decision-making can be enhanced using geriatric assessment https://t.co/DtZOXcozo7 #GeriOnc

— JAMA Oncology (@JAMAOnc) May 13, 2021

Resultados de longo prazo em estudo randomizado confirmam os benefícios da quimiorradioterapia neoadjuvante somada à cirurgia para câncer esofágico.

20 Mai, 2021 | 10:41h

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial – Journal of Clinical Oncology

Comentários no Twitter

Out at @ASCO_pubs
🔟yr Outcome of Neoadj #Chemoradiotherapy➕Surgery for #EsophagealCancer

☑️Show OS benefit in locally advanced resectable esophageal or junctional #Cancer who receive preop chemorad🧪☢️ According to CROSS, persists at least🔟years‼️https://t.co/yJSibSveAh pic.twitter.com/UssnzuFiEe

— Gil Morgan (@weoncologists) May 14, 2021

Survival benefit of preoperative chemoradiotherapy for patients with esophageal cancer persists – 10-year outcome of the CROSS trial https://t.co/s02sMVpYhI #esocsm #JCO @ErasmusMC @bmeyck pic.twitter.com/2JwV0iOvoB

— ASCO Publications (@ASCO_pubs) May 5, 2021

Diretriz USPSTF: Iniciar o rastreamento para câncer colorretal aos 45 anos para a maioria dos pacientes.

19 Mai, 2021 | 09:39h

Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement

Relatório de evidências: Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Editoriais: US Preventive Services Task Force Recommendations for Colorectal Cancer Screening: Forty-Five Is the New Fifty – JAMA E Updated USPSTF Guidelines for Colorectal Cancer Screening: The Earlier the Better – JAMA Surgery E Colorectal Cancer Screening Starting at Age 45 Years—Ensuring Benefits Are Realized by All – JAMA Network Open

Estudo: Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force – JAMA

Entrevista com o autor: USPSTF Recommendation: Screening for Colorectal Cancer

Página do paciente JAMA: Screening for Colorectal Cancer

Guia para potencializar a recuperação de pacientes oncológicos submetidos a cirurgia: ERAS para pacientes de cirurgia citorredutora com ou sem quimioterapia hipertérmica intraperitoneal.

19 Mai, 2021 | 09:24h

Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: ERAS for Patients Undergoing Cytoreductive Surgery with or Without HIPEC – Annals of Surgical Oncology

Diretrizes relacionadas:

Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS®) Society Recommendations — Part I: Preoperative and intraoperative management

Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced Recovery After Surgery (ERAS®) Society Recommendations — Part II: Postoperative management and special considerations

Ver também: Enhanced Recovery After Surgery (ERAS) Society Guidelines

Revisão atualizada do tratamento para tumores estromais gastrintestinais avançados.

13 Mai, 2021 | 10:01h

An updated review of the treatment landscape for advanced gastrointestinal stromal tumors – Cancer